A bacterial strain that produces a family of antibiotic compounds known as the apoptolidins. The predominant compound produced is apoptolidin A.
*Applications include antibiotic and anticancer lead compound development.
*Benefits include increased yield compared to published strains.
INDUSTRY RESEARCH SPONSOR
COLLABERATIVE RESEARCH OPPORTUNITY
Background of the invention: Apoptolidin is a macrolide. It was originally identified on the basis of its ability to selectively kill E1A and E1A/E1B19K transformed rat glial cells.
Available under a nonexclusive biological material license
Joe Christison, Intellectual Property and Licensing Manager
P (541) 737-9016